Navigation Links
Arthritis drugs safer than previously declared

A recently done review of findings published earlier, proves that the previous report exaggerated the risk that two drugs// show in raising the risk of cancer in those who use them.

Research done by Dr. Eric Matteson and colleagues at the Mayo Clinic in Rochester, New York in May 2006, dealing with the study of two drugs 'Humira' and 'Remicade' used currently by physicians to treat rheumatoid arthritis surfaced with findings that pointed out a heavy probability of development of cancer and infections like tuberculosis, in those who use them regularly.This information was was exhibited on labels according to the order of the FDA six months earlier.

However several teams of researchers have since then studied the same drugs all over again in a review to re affirm if they actually triple the chances of cancerous lesions and infections. Their review has projected new data which hints that risk of cancer is not as high as that was proclaimed in the previous studies. The Journal of the American Medical Association has published a number of letters from researchers who have reviewed the drugs again which claims that the use of drug Humira and Remicade only doubles the chances of carcinoma and may work against other auto immune diseases such as skin conditions such as psoriasis, ulcerative colitis.

Almost all the researchers, and the U.S. FDA feel in unison that it is the right of every to know about the risks but also opine that the benefits reflect that the drugs should stay on the market.

Matteson and his colleagues re did the analysis done in May and after considering certain data which were not analysed earlier reached the conclusion that the drugs may not triple the chances of cancer but only double the chances as these two drugs act on the auto immune system blocking the action of TNF-alpha one of the target compounds which mistakenly signals to the immune system to attack the joints as in rheumatoid arthritis.It is now an established fact that any drug that is capable of modifying the immune system can also cause cancer.

Another drug of the same class Enbrel is also being studied by researchers to look into possibilities of causing cancer or infections.

The market for drugs to treat Rheumatoid arthritis is on an upswing following the increase in number of Americans that are affected by rheumatoid arthritis according to the findings noted by market research company Research and Markets.
MST
'"/>




Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Naked DNA Vaccination May Conquer Arthritis and Multiple Sclerosis
3. B Vitamin protects and lowers toxicity of Arthritis Drug
4. FDA Approves New Arthritis Drug, Bextra
5. Risk Of Developing Arthritis
6. Arthritis Drug May Cause Liver Damage
7. Arthritis drug can prolong life
8. New treatment for Rheumatoid Arthritis
9. Important cause of Arthritis
10. Personality Impacts Arthritis
11. New Rheumatoid Arthritis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... ... Driving Dynamics Inc., announced today it has been selected as a 2017 ... its mission to continually monitor the training marketplace for the best providers of training ... and Safety Training Companies list was based on the following criteria: , ...
(Date:9/19/2017)... ... September 19, 2017 , ... The ISO 9001 standard sets out ... organizations become more efficient and improve customer satisfaction. ISO 9001:2015 was released in 2015 ... with a deadline of September 2018. , As described in this ...
(Date:9/19/2017)... ... ... Bone Solutions Inc. (BSI), an orthobiologics technology company located ... OsteoCrete® bone void filler is designed to assist with bone repair and generation, ... for bone health and development. , “We’re excited to bring this important orthopedic ...
(Date:9/19/2017)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... of its Pflugerville- FM 685 facility. , “We are pleased to announce Dr. ... said Dr. Stephen Van Roekel, Reginal Medical Officer of First Choice Emergency Room – ...
(Date:9/19/2017)... ... September 19, 2017 , ... The Davidson Institute for Talent ... on September 27 at a reception in Washington D.C. The recipients received $50,000, ... Music. , “I am honored to be a Davidson Fellow Laureate,” said Rishab ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... WAYNE, N.J. , Sept. 5, 2017 /PRNewswire/ ... technology, has created a vibrant charitable donation program ... funds and support congenital heart defect research by ... healthcare providers and the general public are encouraged ... and submit the completed artwork to the ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/28/2017)... , Aug. 28, 2017   Aesculight ®, a division of ... surgical lasers. Built on over 20 years of American veterinary laser ... New and Exclusive VetScalpel®Features and Enhancements ... Duclos, DVM, is excising a tumor with his new VetScalpel laser. Dr. ... Lynnwood, WA. ...
Breaking Medicine Technology: